Clinical trials: Endocytoscopy, active
Endocytoscopy
Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colorectal Lesions
Colorectal cancer (colorectal cancer, CRC) is the third most common malignant tumor globally and the second leading cause of cancer-related deaths.
- Trial name
- NCT06982872
- Testing
- artificial intelligence
- Where
- China
- Volunteers
- 500 people
- Sponsor
- The First Hospital of Jilin University
Colorectal Polyp
Clinical Study on the Accuracy of Real-time AI-assisted Endocytoscopy in the Diagnosis of Colorectal Diminutive Polyps
Colorectal cancer (CRC) is the third most common malignant tumor in the world and the second largest cause of cancer-related death [1].
- Trial name
- NCT06791408
- Where
- China
- Volunteers
- 600 people
- Sponsor
- The First Hospital of Jilin University
Esophageal Cancer, Squamous Cell
Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia
In recent years, endocytoscopy (EC) has undergone rapid development as an advanced endoscopic technique. Characterized by real-time histological imaging and detection capabilities, EC enables visualization of living cells in the…
- Trial name
- NCT06984055
- Where
- China
- Volunteers
- 600 people
- Sponsor
- Changhai Hospital
Endocytoscopy
Clinical Study on the Diagnosis of Colorectal Lesions by Real-time Artificial Intelligence Assisted Endocytoscopy Combined With Narrow Band Imaging
Colorectal cancer (colorectal cancer, CRC) is the third most common malignant tumor globally and the second leading cause of cancer-related deaths.
- Trial name
- NCT06982885
- Testing
- artificial intelligence
- Where
- China
- Volunteers
- 500 people
- Sponsor
- The First Hospital of Jilin University